Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 3, 2016, Pages 497-504

  Sloane, David ^a   Govindarajulu, Usha ^a,b   Harrow Mortelliti, Jacob ^a   Barry, William ^c   Hsu, Florence Ida ^a   Hong, David ^a   Laidlaw, Tanya ^a   Palis, Ross ^a   Legere, Henry ^a   Bunyavanich, Supinda ^a   Breslow, Rebecca ^a   Wesemann, Duane ^a   Barrett, Nora ^a   Brennan, Patrick ^a   Chong, Hey Jin ^a   Liu, Anne ^a   Fernandez, James ^a   Fanning, Laura ^a   Kyin, Timothy ^a   Cahill, Katherine ^a   Bankova, Lora ^a   Lynch, Ashly ^a   Berlin, Suzanne ^c   Campos, Susana ^c   Fuchs, Charles ^c   Mayer, Robert ^c   Matulonis, Ursula ^c   Castells, Mariana ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carboplatin; Chemotherapeutic agents; Cost; Drug desensitization; Drug hypersensitivity; Efficacy; Monoclonal antibodies; Safety

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TOCILIZUMAB; TRASTUZUMAB;

ADULT; AGED; ANEMIA; ARTHRITIS; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BREAST CANCER; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DESENSITIZATION; DRUG HYPERSENSITIVITY; ENDOMETRIUM CANCER; FEMALE; GONADOBLASTOMA; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LIFE EXPECTANCY; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PERITONEUM CANCER; PHARYNX CANCER; POLYMYOSITIS; PROGRAM EFFICACY; PROSTATE CANCER; RAPID DRUG DESENSITIZATION; SAFETY; SKIN TEST; STOMACH CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TESTIS CANCER; THROMBOCYTOSIS; THYROID CANCER; TONGUE CANCER; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; UTERINE TUBE TUMOR; UTERUS CANCER; VAGINA CANCER; WALDENSTROEM MACROGLOBULINEMIA; WEGENER GRANULOMATOSIS; ADVERSE EFFECTS; ECONOMICS; MIDDLE AGED; NEOPLASMS; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 84959297309     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2015.12.019     Document Type: Article

References (17)

1. O'Donovan W.J., Klorfajn I. Sensitivity to penicillin:anaphylaxis and desensitization. Lancet 1946, 2(6422):444-446.
2. Borish L., Tamir R., Rosenwasser L.J. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987, 80:314-319.
3. Wendel G.D., Stark B.J., Jamison R.B., Molina R.D., Sullivan T.J. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985, 312:1229-1232.
4. Legere H.J., Palis R.I., Rodriguez Bouza T., Uluer A.Z., Castells M.C. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros 2009, 8:418-424.
5. Castells M., Tennant N.M., Sloane D.E., Hsu F.I., Barrett N.A., Hong D.I., et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008, 122(3):574-580.
6. Hesterberg P.E., Banerji A., Oren E., Penson R.T., Krasner C.N., Seiden M.V., et al. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. J Allergy Clin Immunol 2009, 123:1262-1267.e1.
7. Patil S.U., Long A.A., Ling M., Wilson M.T., Hesterberg P., Wong J.T., et al. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. J Allergy Clin Immunol 2012, 129:443-447.
8. Wong J.T., Ling M., Patil S., Banerji A., Long A. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. J Allergy Clin Immunol Pract 2014, 2:40-45.
9. Hirano S., Tsumoto S., Okuzaki T., Hata Y. A clustering method based on rough sets and its application to knowledge discovery in the medical database. Stud Health Technol Inform 2001, 84:206-210.
10. Rosenbaum P.R., Rubin D.B. Difficulties with regression analyses of age-adjusted rates. Biometrics 1984, 40:437-443.
11. Lenz H.J. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007, 12:601-609.
12. Brennan P.J., Rodriguez Bouza T., Hsu F.I., Sloane D.E., Castells M.C. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009, 124:1259-1266.
13. Liu A., Fanning L., Chong H., Fernandez J., Sloane D., Sancho-Serra M., et al. Desensitization regimens for drug allergy: state of the art in the 21st century. Clin Exp Allergy 2011, 41:1679-1689.
14. Madrigal-Burgaleta R., Berges-Gimeno M.P., Angel-Pereira D., Ferreiro-Monteagudo R., Guillen-Ponce C., Pueyo C., et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy 2013, 68:853-861.
15. Gastaminza G., de la Borbolla J.M., Goikoetxea M.J., Escudero R., Antón J., Espinós J., et al. A new rapid desensitization protocol for chemotherapy agents. J Investig Allergol Clin Immunol 2011, 21:108-112.
16. Lindelof B., Granath F., Tengvall-Linder M., Ekbom A. Allergy and cancer. Allergy 2005, 60:1116-1120.
17. Sancho-Serra M., Simarro M., Castells M. Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization. Eur J Immunol 2011, 41:1004-1013.